HighVista Strategies’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $989K | Sell |
20,953
-22,588
| -52% | -$1.07M | 0.36% | 109 |
|
|
2025
Q1 | $1.7M | Hold |
43,541
| – | – | 0.66% | 52 |
|
|
2024
Q4 | $2.36M | Hold |
43,541
| – | – | 0.88% | 32 |
|
|
2024
Q3 | $2.2M | Buy |
43,541
+1,292
| +3% | +$65.1K | 0.76% | 39 |
|
|
2024
Q2 | $1.86M | Sell |
42,249
-17,520
| -29% | -$770K | 0.68% | 44 |
|
|
2024
Q1 | $3M | Hold |
59,769
| – | – | 1.07% | 26 |
|
|
2023
Q4 | $3.61M | Hold |
59,769
| – | – | 1.31% | 23 |
|
|
2023
Q3 | $3.41M | Sell |
59,769
-69,953
| -54% | -$3.99M | 1.58% | 14 |
|
|
2023
Q2 | $6.62M | Buy |
129,722
+7,521
| +6% | +$384K | 3.03% | 2 |
|
|
2023
Q1 | $2.61M | Buy |
+122,201
| New | +$2.61M | 2.13% | 12 |
|